Effects of quingestanol acetate on the histology, histochemistry, and ultrastructure of the human endometrium.
D000135:Acid Phosphatase / Q000378:metabolism; D000328:Adult; D000469:Alkaline Phosphatase / Q000378:metabolism; D001665:Binding Sites; D001706:Biopsy; D003267:Contraception; D003276:Contraceptives, Oral / Q000494:pharmacology*; D004717:Endometrium / Q000166:cytology / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism / Q000648:ultrastructure; D005260:Female; D005640:Follicle Stimulating Hormone / Q000037:antagonists & inhibitors; D006651:Histocytochemistry; D006652:Histological Techniques; D006801:Humans; D007986:Luteinizing Hormone / Q000037:antagonists & inhibitors; D008598:Menstruation; D008853:Microscopy; D008854:Microscopy, Electron; D008875:Middle Aged; D009649:Norpregnadienes / Q000378:metabolism / Q000494:pharmacology*; D010060:Ovulation; D010974:Platelet Aggregation / Q000187:drug effects; D013385:Succinate Dehydrogenase / Q000378:metabolism
D003276:Contraceptives, Oral; D009649:Norpregnadienes; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013385:Succinate Dehydrogenase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase